Stryker Corporation (NYSE:SYK) Receives $427.50 Consensus PT from Analysts

Shares of Stryker Corporation (NYSE:SYK) have been assigned a consensus recommendation of “Moderate Buy” from the nineteen analysts that are presently covering the firm, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and fourteen have issued a buy recommendation on the company. The average 12-month price target among analysts that have issued a report on the stock in the last year is $427.50.

A number of equities analysts have issued reports on the stock. Evercore set a $390.00 target price on shares of Stryker in a research report on Monday, January 5th. Needham & Company LLC increased their price target on shares of Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a research report on Friday, January 30th. Sanford C. Bernstein raised their price objective on shares of Stryker from $450.00 to $465.00 and gave the stock an “outperform” rating in a research note on Friday, January 9th. BTIG Research lifted their price objective on Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Finally, Citigroup reiterated a “market outperform” rating on shares of Stryker in a report on Friday, January 30th.

Insider Activity at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the stock in a transaction on Wednesday, February 4th. The stock was sold at an average price of $362.92, for a total transaction of $90,730,000.00. Following the sale, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 5.90% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. Clayton Financial Group LLC purchased a new position in shares of Stryker during the third quarter valued at approximately $26,000. Godfrey Financial Associates Inc. acquired a new stake in Stryker during the fourth quarter worth approximately $26,000. Sankala Group LLC purchased a new stake in Stryker in the 4th quarter worth approximately $26,000. United Financial Planning Group LLC acquired a new position in Stryker in the 3rd quarter valued at $27,000. Finally, Atlas Capital Advisors Inc. purchased a new position in shares of Stryker during the 4th quarter worth $27,000. 77.09% of the stock is currently owned by hedge funds and other institutional investors.

Stryker Trading Up 1.5%

Shares of SYK stock opened at $332.58 on Tuesday. Stryker has a fifty-two week low of $324.93 and a fifty-two week high of $404.87. The stock has a market cap of $127.37 billion, a P/E ratio of 39.59, a P/E/G ratio of 1.92 and a beta of 0.85. The business has a fifty day simple moving average of $360.91 and a 200-day simple moving average of $364.35. The company has a quick ratio of 1.21, a current ratio of 1.89 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last released its quarterly earnings data on Thursday, January 29th. The medical technology company reported $4.47 EPS for the quarter, topping the consensus estimate of $4.40 by $0.07. The business had revenue of $7.17 billion for the quarter, compared to analyst estimates of $7.12 billion. Stryker had a net margin of 12.92% and a return on equity of 24.41%. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. During the same period in the previous year, the firm earned $4.01 EPS. On average, analysts forecast that Stryker will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 30th. Stockholders of record on Tuesday, March 31st will be given a $0.88 dividend. This represents a $3.52 annualized dividend and a dividend yield of 1.1%. The ex-dividend date is Tuesday, March 31st. Stryker’s dividend payout ratio is currently 41.90%.

About Stryker

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.